RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

AlidaBio today announced the launch of the EpiPlex™ Duo-Mod™ Service, a turnkey offering that maps and quantifies m6A and ...

Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA. A research team led by Professor Won Jong Kim from the Department of Chemistry at POSTECH, ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

Outcome of chemo-immunotherapy for extensive-stage small-cell lung cancer according to potential clinical trial eligibility: 3-year outcomes from prospective cohort study. Tifcemalimab combined with ...

Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid mRNA to the intestines, producing gene expression and reducing inflammation ...

Mast interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines to understand how the company arrived at ...